An ImmunoModulatory and Myotrophic Formulation with Simultaneous Neurotrophic Properties for The Treatment of ALS and Multiple Sclerosis IMMUNOMODULATION SARM
Description
An Immunomodulatory Formulation consisting of Nf-Kappa B , TNF-A and IL-6 Suppressive Protopanaxatriol Class Glucopyranoside Analouges, A Neurotrophic Protobioside Analouge that Promotes Myelin Regeneration , A Myotrophic Bioceutical Extract with Partial SARM-Like Effects thus increasing Muscle Mass via Protein Synthesis Enhancement , via GDF-8 Suppression, increasing intramascular MGF and IGF-1 mRNA Expression and Enhancing Cholinergic Neuromascular Transmission Duration. By Inhibiting Pro-Inflammatory Cytokine Release and via increasing Selective Anabolism Formulation Serves as an Effective Adjunctive Treatment for ALS and Multiple Sclerosis.
Inventors : Erdal Can ALKOCLAR
Metehan YESIl
Producer
Latest update
April 23, 2020
License
Creative Commons Attribution 4.0
Metadata quality:
Data description filled
Files documented
License filled
Update frequency not followed
File formats are closed
Temporal coverage not set
Spatial coverage not set
All files are available
Metadata quality
Update frequency not followed
File formats are closed
Temporal coverage not set
Spatial coverage not set
There are no reuses for this dataset yet.
There are no discussions for this dataset yet.
There are no community resources for this dataset yet.
Information
Tags
License
ID
5ea13ab9f176a10bfcd9d7f0
Temporality
Creation
April 23, 2020
Frequency
Annual
Latest update
April 23, 2020